Coherus Bio (CHRS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2018 | 12-2017 | 12-2016 | 12-2015 | 12-2014 | |
| Sales | 0 | 1,556 | 190,106 | 30,041 | 31,106 |
| Gross Profit | N/A | 1,556 | 190,106 | 30,041 | 31,106 |
| Operating Expenses | 204,416 | 233,692 | 306,037 | 249,108 | 95,788 |
| Operating Income | -204,416 | -232,136 | -115,931 | -219,067 | -64,682 |
| Interest Expense | 9,684 | 9,552 | 7,980 | 33 | 3,900 |
| Other Income | 4,691 | 3,402 | -3,877 | -4,838 | -18,595 |
| Pre-tax Income | -209,409 | -238,286 | -127,788 | -223,938 | -87,177 |
| Net Income Continuous | -209,409 | -238,286 | -127,788 | -223,938 | -87,177 |
| Minority Interests | -70 | -116 | -451 | -678 | -44 |
| Net Income | $-209,339 | $-238,170 | $-127,337 | $-223,260 | $-87,133 |
| EPS Basic Total Ops | -3.22 | -4.48 | -3.04 | -6.01 | -10.64 |
| EPS Basic Continuous Ops | -3.22 | -4.48 | -3.05 | -6.03 | -10.65 |
| EPS Diluted Total Ops | -3.22 | -4.48 | -3.04 | -6.01 | -10.64 |
| EPS Diluted Continuous Ops | -3.22 | -4.48 | -3.05 | -6.03 | -10.65 |
| EPS Diluted Before Non-Recurring Items | -3.22 | N/A | N/A | N/A | N/A |
| EBITDA(a) | $-201,181 | $-228,738 | $-112,935 | $-217,198 | $-64,008 |